The human body is equipped with an efficient protection system against hypocalcemia. This system is composed of parathyroid glands, bone, kidney, and intestine. By appropriate actions of parathyroid hormone (PTH) and active vitamin D (1,25-dihydroxyvitamin D), a small fall of extracellular calcium ion concentration is instantly corrected. Thus, a defect of any step in this system results in the development of hypocalcemia. Overloaded calcium either from bone or intestine is efficiently excreted into the urine. Thus, hypercalcemia develops almost exclusively when a greater amount of calcium than the kidney can excrete is loaded. In chronic dialysis patients, either hypocalcemia or hypercalcemia may develop because of defects in these two defense systems against calcium imbalance.

Keywords:
Calcium, Parathyroid, Parathyroid hormone, Vitamin D, Kidney, Hypercalcemia, Hypocalcemia
1.
Kurokawa K: The kidney and calcium homeostasis. Kidney Int 1994;45(suppl 44):S97–S105.
2.
Akizawa T, Fukagawa M: Modulation of parathyroid cell function by calcium ion in health and uremia. Am J Med Sci 1999;317:358–362.
3.
Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC: Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 1993;366:575–580.
4.
Brown EM, MacLead RJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001;81:239–297.
5.
Gogusev J, Duchambon P, Hory B, Giovanninni M, Goureau Y, Sarfati E, Drueke TB. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997;51:328–336.
6.
Delmez JA, Tindra C, Grooms P, Dusso A, Windus DW, Slatopolsky E: Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: A role for increased sensitivity to calcium. J Clin Invest 1989;83:1349–1355.
7.
Pollak M, Brown EM, Chou Y-HW, Hebert SC, Marx SJ, Steinnmann B, et al: Mutation in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993;75:1297–1303.
8.
Pollak M, Brown EM, Kifor O, Estep H, Seidman C, Seidman JG: Autosomal dominant hypocalcemia due to an activating mutation in the human extracellular Ca2+-sensing receptor gene. Nat Genet 1994;8:303–308.
9.
Yamamoto M, Kawanobe Y, Takahashi H, Shimazawa E, Kimura S, Ogata E: Vitamin D deficiency and calcium transport in the rat. J Clin Invest 1984;74:507–513.
10.
Yamamoto M, Takuwa Y, Masuko S, Ogata E: Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in psudohypoparathyroidism. J Clin Endocrinol Metab 1988;66:618–625.
11.
Bushinsky DA: Calcium. Lancet 1998;352:306–311.
12.
Fatemi S, Ryzen E, Flores J, Endres DB, Rude RK: Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991;73:1067–1072.
13.
Hruska KA, Teitelbaum SL: Renal osteodystrophy. N Engl J Med 1995;20:333:166–174.
14.
Gardner DG: Hypercalcemia and sarcoidosis – another piece of the puzzle falls into place. Am J Med 2001;15:736–737.
15.
Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH: Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994;46:855–861.
16.
Hebert SC: Extracellular calcium-sensing receptor: Implications for calcium and magnesium handling in the kidney. Kidney Int 1996;50:2129–2139.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.